Skip to main content
. Author manuscript; available in PMC: 2017 Dec 4.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2016 Apr 12;96(1):119–126. doi: 10.1016/j.ijrobp.2016.04.001

Figure 1.

Figure 1

Event free survival estimate of EWS by disease status. The 5-year EFS was 79.9% ± 9.9% for the localized group and 56.1% ± 14.1% for the metastatic group (p=0.14).